http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-226950-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9a36328274867f46f8fc1fb9c868703
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
filingDate 1999-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcd868bfacab54619678383a5a92f1c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2579c0381bb5462e39ed9f4560a351c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd1efbdbe09368a379570d84a4cfbf02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74ba133e249e4fcc0091a921aeba54e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8571d3dc162295fd5ba0d41d0955b8f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc14bc5399016e6a230d45c21aa9d0ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7949e43be2fd6db8897663341eafc7ce
publicationDate 2010-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-226950-B1
titleOfInvention The magnesium salt of enalapril and antihypertensive pharmaceutical composition containing it
abstract The object of the present invention is the compound of (1S)-N-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-prolin (international name: enalapril) in the form of its alkaline and alkaline earth metal salts and the solvates of these salts of general formula (I) wherein X is calcium, potassium or magnesium. The invention is related to the use of the above titled new salt forms in drugs for the treatment of cardiovascular diseases.
priorityDate 1999-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033859
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6338572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426700827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID83525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449812109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454445837
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453171762
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447665194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14962498
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451646703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415777212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157207043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534469
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505

Total number of triples: 49.